NovaBay Pharmaceuticals, Inc. — Director's Dealing 2017

Jan 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovaBay Pharmaceuticals, Inc. (NBY)
CIK: 0001389545
Period of Report: 2017-01-25

Reporting Person: PAULSON THOMAS J (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-25	stock option (right to buy)	$3.60	A	116000	Acquired	2027-01-25	Common Stock (116000)	Direct

Footnotes

F1: Options granted pursuant to 2007 Omnibus Incentive Plan

F2: the Option will vest on January 31, 2018, in direct proportion to the percentage achievement of the stated 2017 corporate goals, as approved and determined by the Board.